Dysregulation of COL1A1 expression leads to ECM stiffness, impaired adipogenesis, and disrupted lipid metabolism, contributing to metabolic diseases such as obesity and insulin resistance [52]. The gene discussed is COL1A1; the disease is metabolic disease.